PEPFAR decisions to be grounded in scientific evidence, Goosby says

U.S. Global AIDS Coordinator Eric Goosby "said future programmes to prevent HIV infection would be those supported by the best scientific evidence," reports the Financial Times. Goosby told the Financial Times in an interview: "I will always wrap myself in the science as the justification of decision-making. I will not factor in an ideological rationale."

"His comments signal a break with past restrictions on how PEPFAR spent its funding, which constrained its ability to support some of the most effective organisations working with prostitutes, drug users and younger people at highest risk from the virus," the newspaper writes. Goosby said to the newspaper, "We need to have abstinence and fidelity closely linked to condom distribution."

The PEPFAR five-year strategy announced recently "will closely track HIV infections, and emphasise 'prevention strategies that have been proven effective, and [target] interventions to the most at-risk populations with high incidence rates,'" the Financial Times writes. Though PEPFAR's new strategy emphasizes a commitment to prevention and targeting high-risk groups, it "remains scant on detail," the Financial Times writes. The article includes Goosby's views on the success of PEPFAR to date and his thoughts on the program's future (Jack, 12/16).

The webcast of a Kaiser Family Foundation town hall with Goosby to discuss the PEPFAR five-year strategy is available online.


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New two-dose HIV vaccine strategy shows promise for stronger immune response